Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8662 |
High Similarity |
NPD2796 |
Approved |
0.8643 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8643 |
High Similarity |
NPD5124 |
Phase 1 |
0.86 |
High Similarity |
NPD7411 |
Suspended |
0.8487 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8446 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8356 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8345 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD920 |
Approved |
0.8323 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8255 |
Intermediate Similarity |
NPD6799 |
Approved |
0.82 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8092 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8082 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8079 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8052 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7961 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7961 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7959 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7925 |
Intermediate Similarity |
NPD919 |
Approved |
0.7919 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7902 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7867 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7834 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7815 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7736 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7718 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7703 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.766 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7658 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7651 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.76 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7551 |
Intermediate Similarity |
NPD3268 |
Approved |
0.755 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7483 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7455 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7452 |
Intermediate Similarity |
NPD1512 |
Approved |
0.745 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD2797 |
Approved |
0.744 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7412 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD2654 |
Approved |
0.74 |
Intermediate Similarity |
NPD1933 |
Approved |
0.74 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7386 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7355 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7315 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7279 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7247 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7247 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7181 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7176 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD17 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7051 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7022 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7014 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3972 |
Approved |
0.6995 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6993 |
Remote Similarity |
NPD3142 |
Approved |
0.6993 |
Remote Similarity |
NPD3140 |
Approved |
0.6988 |
Remote Similarity |
NPD5353 |
Approved |
0.6981 |
Remote Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD411 |
Approved |
0.6968 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.695 |
Remote Similarity |
NPD5535 |
Approved |
0.6948 |
Remote Similarity |
NPD447 |
Suspended |
0.6948 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6943 |
Remote Similarity |
NPD2344 |
Approved |
0.6943 |
Remote Similarity |
NPD2353 |
Approved |
0.6943 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD8313 |
Approved |
0.6932 |
Remote Similarity |
NPD8312 |
Approved |
0.6928 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD7003 |
Approved |
0.6915 |
Remote Similarity |
NPD7584 |
Approved |
0.6914 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6899 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6897 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6882 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD9493 |
Approved |
0.6849 |
Remote Similarity |
NPD5691 |
Approved |
0.6842 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6839 |
Remote Similarity |
NPD4622 |
Approved |
0.6839 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD4618 |
Approved |
0.6832 |
Remote Similarity |
NPD6652 |
Clinical (unspecified phase) |
0.6825 |
Remote Similarity |
NPD7583 |
Approved |
0.6818 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6816 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD2186 |
Approved |
0.6802 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD1729 |
Discontinued |
0.679 |
Remote Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6789 |
Remote Similarity |
NPD7585 |
Approved |
0.6782 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6781 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6774 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6772 |
Remote Similarity |
NPD4477 |
Approved |
0.6772 |
Remote Similarity |
NPD5408 |
Approved |
0.6772 |
Remote Similarity |
NPD4476 |
Approved |
0.6772 |
Remote Similarity |
NPD2438 |
Suspended |
0.6772 |
Remote Similarity |
NPD5406 |
Approved |
0.6772
|
Remote Similarity |
NPD5404 |
Approved |